Weighted Average Number of Shares Outstanding, Basic of Verrica Pharmaceuticals Inc. from Q2 2021 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Verrica Pharmaceuticals Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from Q2 2021 to Q3 2025.
  • Verrica Pharmaceuticals Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 9.49M shares, a 103% increase year-over-year.
  • Verrica Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 51.8M shares, a 14.3% increase from 2023.
  • Verrica Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 45.3M shares, a 32.7% increase from 2022.
  • Verrica Pharmaceuticals Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 34.2M shares, a 26.3% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Verrica Pharmaceuticals Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 9.49M +4.81M +103% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 9.49M +4.84M +104% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 94.8M +48.4M +104% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025
Q4 2024 51.8M +6.47M +14.3% 01 Oct 2024 31 Dec 2024 10-K 11 Mar 2025
Q3 2024 4.68M -41.4M -89.8% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q2 2024 4.65M -41.3M -89.9% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 46.5M +3.46M +8.04% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025
Q4 2023 45.3M +11.2M +32.7% 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025
Q3 2023 46.1M +5.77M +14.3% 01 Jul 2023 30 Sep 2023 10-Q 05 Nov 2024
Q2 2023 45.9M +18.4M +66.9% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 43M +15.5M +56.3% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 34.2M 01 Oct 2022 31 Dec 2022 10-K 29 Feb 2024
Q3 2022 40.3M +12.8M +46.5% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 27.5M +5.39K +0.02% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 27.5M 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q3 2021 27.5M 01 Jul 2021 30 Sep 2021 10-Q 07 Nov 2022
Q2 2021 27.5M 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022

Verrica Pharmaceuticals Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 51.8M +6.47M +14.3% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025
2023 45.3M +11.2M +32.7% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025
2022 34.2M +7.12M +26.3% 01 Jan 2022 31 Dec 2022 10-K 29 Feb 2024
2021 27M 01 Jan 2021 31 Dec 2021 10-K 06 Mar 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.